ENA Respiratory Expands Leadership Team and Extends U.S. Department of Defense Funding to Enable Phase II Program of INNA-051 in Community-Acquired Viral Respiratory Infections
Globe Newswire29-08-2023, 19:00
Repligen Corporation to Present at KeyBanc Life Science and 14-03-2023, 18:36